$Vertex Pharmaceuticals (VRTX.US)$ NEWS Vertex Pharmaceutica...
NEWS
Vertex Pharmaceuticals Inc expected to post earnings of $4.06 a share - Earnings Preview
Vertex Pharmaceuticals Inc VRTX.OQ VRTX.O is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2024
The Boston Massachusetts-based company is expected to report a 8.6% increase in revenue to $2.579 billion from $2.37 billion a year ago, according to the mean estimate from 23 analysts, based on LSEG data.
LSEG's mean analyst estimate for Vertex Pharmaceuticals Inc is for earnings of $4.06 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy," 9 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Vertex Pharmaceuticals Inc is $456.44, above its last closing price of $401.08.
The Boston Massachusetts-based company is expected to report a 8.6% increase in revenue to $2.579 billion from $2.37 billion a year ago, according to the mean estimate from 23 analysts, based on LSEG data.
LSEG's mean analyst estimate for Vertex Pharmaceuticals Inc is for earnings of $4.06 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy," 9 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Vertex Pharmaceuticals Inc is $456.44, above its last closing price of $401.08.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
739Followers
76Following
4741Visitors
Follow